
Bridget E. Bunner
Examiner (ID: 13118, Phone: (571)272-0881 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647, 1644 |
| Total Applications | 1451 |
| Issued Applications | 718 |
| Pending Applications | 165 |
| Abandoned Applications | 598 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5844217
[patent_doc_number] => 20020132250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'EGF motif protein, EGFL6 materials and methods'
[patent_app_type] => new
[patent_app_number] => 09/981649
[patent_app_country] => US
[patent_app_date] => 2001-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 41179
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132250.pdf
[firstpage_image] =>[orig_patent_app_number] => 09981649
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/981649 | Method of detecting a cancerous cell expressing EGFL6, and EGF mutif protein | Oct 14, 2001 | Issued |
Array
(
[id] => 6642820
[patent_doc_number] => 20030103992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Clasp membrane proteins'
[patent_app_type] => new
[patent_app_number] => 09/978244
[patent_app_country] => US
[patent_app_date] => 2001-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 95
[patent_figures_cnt] => 95
[patent_no_of_words] => 50740
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20030103992.pdf
[firstpage_image] =>[orig_patent_app_number] => 09978244
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/978244 | Clasp membrane proteins | Oct 14, 2001 | Abandoned |
Array
(
[id] => 6782977
[patent_doc_number] => 20030064424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Method of diagnosing transmissible spongiform encephalopathies'
[patent_app_type] => new
[patent_app_number] => 09/974131
[patent_app_country] => US
[patent_app_date] => 2001-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6873
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20030064424.pdf
[firstpage_image] =>[orig_patent_app_number] => 09974131
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/974131 | Method of diagnosing transmissible spongiform encephalopathies | Oct 7, 2001 | Abandoned |
Array
(
[id] => 5787123
[patent_doc_number] => 20020160425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Process for differential diagnosis of Alzheimer\'s dementia and device therefor'
[patent_app_type] => new
[patent_app_number] => 09/971740
[patent_app_country] => US
[patent_app_date] => 2001-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7177
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160425.pdf
[firstpage_image] =>[orig_patent_app_number] => 09971740
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/971740 | Method for detecting the presence of monomeric brain associated human glutamine synthetase | Oct 3, 2001 | Issued |
| 09/964252 | 56115, a novel human twik potassium channel and uses therefor | Sep 24, 2001 | Abandoned |
Array
(
[id] => 6778646
[patent_doc_number] => 20030049727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => '25658, a novel human calcium channel subunit and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/964256
[patent_app_country] => US
[patent_app_date] => 2001-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 39863
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049727.pdf
[firstpage_image] =>[orig_patent_app_number] => 09964256
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/964256 | 25658, a novel human calcium channel subunit and uses thereof | Sep 24, 2001 | Abandoned |
Array
(
[id] => 6446680
[patent_doc_number] => 20020177227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-28
[patent_title] => 'Modulation of primary stem cell differentiation'
[patent_app_type] => new
[patent_app_number] => 09/962026
[patent_app_country] => US
[patent_app_date] => 2001-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12665
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20020177227.pdf
[firstpage_image] =>[orig_patent_app_number] => 09962026
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/962026 | Modulation of primary stem cell differentiation using an insulin-like growth factor binding protein | Sep 23, 2001 | Issued |
Array
(
[id] => 5859033
[patent_doc_number] => 20020123098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => '55063, a novel human NMDA family member and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/957683
[patent_app_country] => US
[patent_app_date] => 2001-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 38361
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123098.pdf
[firstpage_image] =>[orig_patent_app_number] => 09957683
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/957683 | 55063, a novel human NMDA family member and uses thereof | Sep 18, 2001 | Abandoned |
Array
(
[id] => 5921673
[patent_doc_number] => 20020115112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Neutrokine-alpha and Neutrokine-alpha splice variant'
[patent_app_type] => new
[patent_app_number] => 09/929493
[patent_app_country] => US
[patent_app_date] => 2001-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 182879
[patent_no_of_claims] => 117
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115112.pdf
[firstpage_image] =>[orig_patent_app_number] => 09929493
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/929493 | Neutrokine-alpha and Neutrokine-alpha splice variant | Aug 14, 2001 | Abandoned |
Array
(
[id] => 6745642
[patent_doc_number] => 20030022825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides'
[patent_app_type] => new
[patent_app_number] => 09/912935
[patent_app_country] => US
[patent_app_date] => 2001-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 49940
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022825.pdf
[firstpage_image] =>[orig_patent_app_number] => 09912935
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/912935 | Stem cell growth factor-like polypeptides | Jul 23, 2001 | Issued |
Array
(
[id] => 6669415
[patent_doc_number] => 20030114399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Human and mouse choline transporter cDNA'
[patent_app_type] => new
[patent_app_number] => 09/911077
[patent_app_country] => US
[patent_app_date] => 2001-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 51596
[patent_no_of_claims] => 105
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20030114399.pdf
[firstpage_image] =>[orig_patent_app_number] => 09911077
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/911077 | Human and mouse choline transporter cDNA | Jul 22, 2001 | Abandoned |
Array
(
[id] => 6865085
[patent_doc_number] => 20030190611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/907728
[patent_app_country] => US
[patent_app_date] => 2001-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 125
[patent_figures_cnt] => 125
[patent_no_of_words] => 122300
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190611.pdf
[firstpage_image] =>[orig_patent_app_number] => 09907728
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/907728 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 16, 2001 | Abandoned |
Array
(
[id] => 6813527
[patent_doc_number] => 20030073077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/905088
[patent_app_country] => US
[patent_app_date] => 2001-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 125
[patent_figures_cnt] => 125
[patent_no_of_words] => 118475
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073077.pdf
[firstpage_image] =>[orig_patent_app_number] => 09905088
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/905088 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 11, 2001 | Abandoned |
Array
(
[id] => 6750319
[patent_doc_number] => 20030044839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/902903
[patent_app_country] => US
[patent_app_date] => 2001-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 125
[patent_figures_cnt] => 125
[patent_no_of_words] => 118323
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044839.pdf
[firstpage_image] =>[orig_patent_app_number] => 09902903
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/902903 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 9, 2001 | Abandoned |
Array
(
[id] => 1091793
[patent_doc_number] => 06824781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-30
[patent_title] => 'Method of impairing movement of a CLA memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist'
[patent_app_type] => B2
[patent_app_number] => 09/898751
[patent_app_country] => US
[patent_app_date] => 2001-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31582
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/824/06824781.pdf
[firstpage_image] =>[orig_patent_app_number] => 09898751
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/898751 | Method of impairing movement of a CLA memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist | Jul 1, 2001 | Issued |
Array
(
[id] => 6750272
[patent_doc_number] => 20030044792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Methods and materials relataing to novel stem cell growth factor-like polypeptides and polynucleotides'
[patent_app_type] => new
[patent_app_number] => 09/894912
[patent_app_country] => US
[patent_app_date] => 2001-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 67617
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044792.pdf
[firstpage_image] =>[orig_patent_app_number] => 09894912
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/894912 | Method of promoting stem cell proliferation or survival by contacting a cell with a stem cell factor-like polypeptide | Jun 27, 2001 | Issued |
Array
(
[id] => 6209926
[patent_doc_number] => 20020072493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-13
[patent_title] => 'Activated T cells, nervous system-specific antigens and their uses'
[patent_app_type] => new
[patent_app_number] => 09/893348
[patent_app_country] => US
[patent_app_date] => 2001-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 23035
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20020072493.pdf
[firstpage_image] =>[orig_patent_app_number] => 09893348
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/893348 | Activated T cells, nervous system-specific antigens and their uses | Jun 27, 2001 | Abandoned |
Array
(
[id] => 948940
[patent_doc_number] => 06962976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-08
[patent_title] => 'Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and niluzole'
[patent_app_type] => utility
[patent_app_number] => 09/892360
[patent_app_country] => US
[patent_app_date] => 2001-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7526
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/962/06962976.pdf
[firstpage_image] =>[orig_patent_app_number] => 09892360
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/892360 | Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and niluzole | Jun 26, 2001 | Issued |
Array
(
[id] => 634008
[patent_doc_number] => 07129064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-31
[patent_title] => 'Canine hepatocyte growth factor'
[patent_app_type] => utility
[patent_app_number] => 10/311776
[patent_app_country] => US
[patent_app_date] => 2001-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9297
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/129/07129064.pdf
[firstpage_image] =>[orig_patent_app_number] => 10311776
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/311776 | Canine hepatocyte growth factor | Jun 21, 2001 | Issued |
Array
(
[id] => 6847101
[patent_doc_number] => 20030166268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Mammalian transforming growth factor beta-10'
[patent_app_type] => new
[patent_app_number] => 09/867964
[patent_app_country] => US
[patent_app_date] => 2001-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18674
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166268.pdf
[firstpage_image] =>[orig_patent_app_number] => 09867964
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/867964 | Mammalian transforming growth factor beta-10 | May 28, 2001 | Abandoned |